The researchers of a new phase 3 clinical trial presented at the ACG 2019 Annual Meeting sought to determine the safety and efficacy of budesonide oral suspension in adolescents and adults with EoE.
The authors of a new study evaluated more than 4000 cases of Campylobacter infection to estimate the US incidence of Campylobacter infection–associated postinfectious irritable bowel syndrome.
The FDA has expanded the approval of a new option for the treatment of adults and children aged 12 years or older or weighing at least 99 pounds with chronic hepatitis C virus genotypes 1, 2, 3, 4, 5, or 6...
Authors of a new study evaluated the impact of tenofovir disoproxil fumarate on outcomes of more than 1000 individuals with chronic hepatitis B virus infection with cirrhosis.
The NHE3 sodium transport inhibitor was approved for use after results from 2 clinical trials showed increased bowel movements and decreased abdominal pain among individuals with IBS-C.
Edward Barnes, MD, MPH, discussed practical implications to consider when positioning medications in the management of IBD during his presentation at the Advances in Inflammatory Bowel Diseases Regional in...
Stephen Hanauer, MD, from Northwestern Medicine, discussed key windows of opportunity for effective management of Crohn disease during his presentation at the Advances in Inflammatory Bowel Diseases...
The guideline developed by the American Society for Gastrointestinal Endoscopy addressed 5 clinical questions on when and how to screen and survey individuals with Barrett esophagus.
The FDA issued a drug safety warning after more than 60 individuals experienced liver injury after they received treatment with 1 of 3 medications for hepatitis C virus.
